Physician profile
Robert Bryce Robbins
NPI 1861027815
$4,598.86
in general payments reported to CMS, 2019-2025
18 companies · $646 in 2025
The $646 reported for 2025 was more than what 85% of Pediatric Ophthalmology and Strabismus Specialist providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $445 · 2023: $1,435 · 2024: $2,072 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,153.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $907.55 | 2022-2025 | Clareon, Ngenuity, Hydrus Microstent |
| Abbvie INC. | $893.53 | 2022-2025 | Xen Glaucoma Treatment System |
| Glaukos Corporation | $493.98 | 2023-2024 | Idose |
| Bausch & Lomb Americas INC. | $475.79 | 2022-2024 | Envista Mx60 Iol, Xipere, Visudyne |
| Johnson & Johnson Surgical Vision, INC. | $323.89 | 2023-2025 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Dompe US, INC. | $221.51 | 2025 | Oxervate |
| Sight Sciences, INC. | $165.05 | 2024 | Omni Surgical System |
| Genentech, INC. | $136.97 | 2023 | Vabysmo |
| Harrow Eye, LLC | $121.80 | 2024 | Verkazia, Iheezo, Flarex |
| Axogen | $121.30 | 2023 | Avance Nerve Graft |
| New World Medical,INC. | $120.63 | 2024 | Clearpath, Streamline, Kahook Dual Blade |
| Sun Pharmaceutical Industries INC. | $119.21 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $114.15 | 2024 | Eylea Hd |
| Rxsight INC | $112.71 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Astellas Pharma US INC | $98.68 | 2024 | Izervay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $96.39 | 2023 | Forum |
| Tarsus Pharmaceuticals, INC. | $57.00 | 2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $18.72 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.